This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Hydroxyethyl starch solutions should not be used in some critically ill patients
- Starting date:
- June 24, 2013
- Posting date:
- June 24, 2013
- Type of communication:
- Information Update
- Subcategory:
- Drugs
- Source of recall:
- Health Canada
- Issue:
- Important Safety Information
- Audience:
- General Public
- Identification number:
- RA-34299
Issue
Health Canada and the manufacturers of blood volume expanders containing hydroxyethyl starch (HES) solutions recommend that these products no longer be used in critically ill patients with certain health conditions.
HES solutions are used to replace lost blood in patients who are critically ill and experience a sudden drop in blood pressure (for example, following surgery).
Specifically, HES solutions should not be used:
- in patients with sepsis (a serious complication that can develop from an infection),
- in patients with severe liver disease, and
- in certain types of patients with impaired kidney function.
Some recent studies have compared HES with other blood volume expanders in critically ill patients with sepsis. These studies suggest that patients treated with HES are at a higher risk of kidney failure or death.
Health Canada will work with the manufacturers to update the drug labels of these products and will communicate with healthcare professionals and consumers when the labels have been updated.
Media enquiries
Health Canada
(613) 957-2983
Public enquiries
(613) 957-2991
1-866 225-0709